Highbridge Capital Management LLC Protalix Bio Therapeutics, Inc. Transaction History

Highbridge Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.03 - $1.24 $2.49 Million - $2.99 Million	2,413,487 New	2,413,487 $2.51 Million
Q4 2020 Feb 12, 2021	SELL	$3.15 - $3.98 $7.61 Million - $9.61 Million	-2,414,487 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.19 - $4.5 $5.29 Million - $10.9 Million	-2,414,487 Reduced 50.0%	2,414,487 $9.15 Million
Q1 2020 May 15, 2020	BUY	$2.1 - $4.61 $10.1 Million - $22.3 Million	4,828,974 New	4,828,974 $11.3 Million

9.25M

40.6K

10.1K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $57.7M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.